John P. Butler - Mar 1, 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
CEO and President, Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for John P. Butler
Stock symbol
AKBA
Transactions as of
Mar 1, 2023
Transactions value $
-$80,614
Form type
4
Date filed
3/3/2023, 07:01 AM
Previous filing
Mar 1, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$33.6K -38.3K -2.3% $0.88 1.62M Mar 1, 2023 Direct F1
transaction AKBA Common Stock Sale -$41.5K -47.2K -2.91% $0.88 1.58M Mar 1, 2023 Direct F2
transaction AKBA Common Stock Sale -$5.59K -6.37K -0.4% $0.88 1.57M Mar 1, 2023 Direct F3
holding AKBA Common Stock 100K Mar 1, 2023 Held By John Butler GRAT November 2019
holding AKBA Common Stock 59.9K Mar 1, 2023 Held by John Butler 2019 GRAT
holding AKBA Common Stock 100K Mar 1, 2023 Held By Dorothy Butler GRAT November 2019
holding AKBA Common Stock 59.9K Mar 1, 2023 Held by Dorothy Butler 2019 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
F2 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
F3 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.